Exscientia

Recursion is a leading AI-driven drug discovery company that uses advanced artificial intelligence and extensive biological data to develop innovative treatments for cancers, rare diseases, and other conditions. Their proprietary platform and strategic partnerships enable faster, more efficient drug development with a focus on first-in-class medicines.